SAWAI GROUP HOLDINGS Co., Ltd. (JP:4887) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Sawai Group Holdings has secured exclusive marketing rights for a pioneering therapeutic app developed by CureApp Inc. aimed at reducing alcohol intake in Japan. The agreement includes milestone payments up to 4.8 billion yen to CureApp, with future royalties on sales post-launch. This app, which is awaiting regulatory approval, represents Japan’s first medical device of its kind to potentially receive insurance coverage as a digital therapy for alcohol dependence.
For further insights into JP:4887 stock, check out TipRanks’ Stock Analysis page.